about
Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activationStructure of a Sliding Clamp on DNAStructure of a small-molecule inhibitor of a DNA polymerase sliding clampStructural and Functional Studies of Aspergillus oryzae Cutinase: Enhanced Thermostability and Hydrolytic Activity of Synthetic Ester and Polyester DegradationStructural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based ImmunogensConserved structural elements in the V3 crown of HIV-1 gp120Structure of the Pentameric Ligand-Gated Ion Channel GLIC Bound with Anesthetic KetamineHuman Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic StructureViral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization BreadthStructure of the pentameric ligand-gated ion channel ELIC cocrystallized with its competitive antagonist acetylcholineFunctional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individualsRabbit Anti-HIV-1 Monoclonal Antibodies Raised by Immunization Can Mimic the Antigen-Binding Modes of Antibodies Derived from HIV-1-Infected HumansFunctional Implications of the Binding Mode of a Human Conformation-Dependent V2 Monoclonal Antibody against HIVOrganization of uroplakin subunits: transmembrane topology, pair formation and plaque compositionAn arsenite-inducible 19S regulatory particle-associated protein adapts proteasomes to proteotoxicityThe V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel.Selective enrichment and fractionation of phosphopeptides from peptide mixtures by isoelectric focusing after methyl esterification.Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold.Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNA.Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.pH-dependent conformational switch activates the inhibitor of transcription elongation.Structure-based functional characterization of repressor of toxin (Rot), a central regulator of Staphylococcus aureus virulence.Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting VirusesRationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies.Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding.Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFLStructural basis for tetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-A resolution.Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coliContrasting antibody responses to intrasubtype superinfection with CRF02_AG.Characteristics of the phagocytic cup induced by uropathogenic Escherichia coli.Sequential and compartmentalized action of Rabs, SNAREs, and MAL in the apical delivery of fusiform vesicles in urothelial umbrella cellsDistinct Residues Contribute to Motility Repression and Autoregulation in the Proteus mirabilis Fimbria-Associated Transcriptional Regulator AtfJ.Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines.Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.Determinants of HIV-1 CD4-independent brain adaptation.Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies.Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.Identification of conserved amino acids in murine B7-1IgV domain critical for CTLA4/CD28:B7 interaction by site-directed mutagenesis: a novel structural model of the binding site.
P50
Q27625275-FDA3787C-7B7A-4AD4-AA8C-9ED2EFDDDCF5Q27649528-113787D5-647E-472A-975D-CE53816CC306Q27651408-E2324677-1360-4644-A759-DA8915726ACBQ27657711-55D3C87F-F230-482C-8BE8-29174344DE36Q27658173-E8C4124F-4546-4C38-9266-44D3828BB87FQ27663325-2F1D6856-3568-4A84-8F70-FF3C8BDC402AQ27672696-E9B38245-7572-4B58-97FD-8EEC9021A031Q27676155-B123057B-CFBD-4BA1-892C-FD4F80986FEFQ27676728-79F92FA2-D0C9-4288-BCCD-29E656107B57Q27677870-8F081EF6-2269-4E50-8F0D-169D9E471B0FQ27677941-E189161E-CA66-449C-AE7C-A5A699F3F136Q27679123-C2C2A7F6-65FE-481F-A4CC-AB06D2C1A558Q27681527-16B04627-21C0-42D2-92FC-05A409551D65Q28360592-B7009CDD-7DE8-443C-A9D1-4D8E3BB9A8CFQ28589336-7998166A-88C0-48E7-9E2D-09462D9B1088Q30152923-C178E211-D797-43D0-8ECD-EDBFA1EBACDAQ33270176-0F1E6920-7BED-404C-BD90-813A5D9462FEQ34091371-15294628-4C20-47F2-8750-A28546CD4F6DQ34128200-97F4C334-4C5F-4079-8D5D-3FE599DAFC9CQ34204047-053ED380-DBC5-46E8-8A1B-FADC6CD87300Q34540352-22B0F960-FC95-4EB8-AD40-CDF1E1531413Q34619759-BE265A1D-89E0-4682-A204-350EC95D69CCQ34888184-1B749E20-DCC1-48EA-B622-F6D89BAAF9D9Q34948847-430F1ABA-5686-4C26-95FB-79B8BD62400DQ35817106-80E5C5F1-AAF8-4A4C-9382-E9B8A6CE95F1Q35909563-002B0B8D-F974-4EFE-8D78-8000D6AA72D1Q35913910-7878CF22-EFD8-4FF8-85FA-AE4FCACBF6B5Q36117676-54B2ED27-1A46-4AB8-8230-D75B3E2145CFQ36262315-B599F82E-ED8A-426F-9040-7C1B1ADE94ECQ36306344-02C7EAB0-9C76-4BE0-9CA4-5E2D34B6C5A2Q36662241-7E6121FA-C5D6-41D5-A713-5DF68C29B27CQ36896310-510D789E-D99F-484B-9CF0-77DB729F105AQ37093379-1B5F2F3F-9B0A-4B2E-B07C-A0026A06C84CQ37419234-7AFED5CB-B9AF-4E65-9389-1E0FB0F43012Q37448281-69FACD71-5797-4AD5-8520-3A0E4A2CBF30Q38719228-F188C751-BC9F-487A-8E52-DA7CD53E1DD1Q38862338-DC523CF8-886E-456D-8251-9D32FEAAB094Q38968180-68510A2B-7BE0-45AD-8AA1-3AA0CE33A7BAQ39314021-90F87B24-44E4-40F4-A889-81A524DC9741Q41009237-83C1F53D-3CFB-4FF3-8148-29959C4229F7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Xiang-Peng Kong
@ast
Xiang-Peng Kong
@en
Xiang-Peng Kong
@es
Xiang-Peng Kong
@sl
type
label
Xiang-Peng Kong
@ast
Xiang-Peng Kong
@en
Xiang-Peng Kong
@es
Xiang-Peng Kong
@sl
altLabel
Xiangpeng Kong
@en
prefLabel
Xiang-Peng Kong
@ast
Xiang-Peng Kong
@en
Xiang-Peng Kong
@es
Xiang-Peng Kong
@sl
P106
P31
P496
0000-0001-5773-2681